IDENTITY
CompoundGHK-Cu (Copper Tripeptide-1)
BrandDragon Pharma
Strength50 mg
FormLyophilized Peptide Powder
ClassPeptide / Research Compound
PEPTIDE PROFILE
StructureTripeptide-Copper Complex
Amino SequenceGly-His-Lys Copper Binding Peptide
AdministrationSubcutaneous Research Administration
Biological RoleTissue Remodeling Signal
CategoryRegenerative Peptide
PHARMACOLOGY
Primary TargetCopper-Dependent Cellular Pathways
ActivityExtracellular Matrix Regulation
Collagen SupportIncreased Fibroblast Signaling
Anti-InflammatoryPotential Modulation
SourceEndogenous Human Peptide
STORAGE & PACKAGE
BrandDragon Pharma
Package50 mg Multi-dose Vial
Storage2°C–8°C Recommended
ProtectionProtect From Light
FormFreeze-Dried Powder
USAGE PROFILE
Research ApplicationSkin & Tissue Biology
Bodybuilding InterestRecovery Support
Administration RouteSubcutaneous Injection
Typical Research Time4–12 Weeks
FrequencyDaily or Scheduled Protocols
ADMINISTRATION
ReconstitutionBacteriostatic Water Used in Research Settings
Injection SiteSubcutaneous Area
FrequencyDaily Administration Common in Research
HandlingAseptic Technique Required
StabilityTemperature Sensitive Peptide
DOSING INFORMATION
Research Range1–5 mg/day
Lower Protocol1 mg/day
Moderate Protocol2–3 mg/day
Higher Research Range5 mg/day
Duration4–12 Weeks
RECOVERY PROFILE
Tissue RepairCellular Remodeling Support
Skin QualityCollagen Pathway Support
Training RecoveryPotential Connective Tissue Support
Muscle DamageResearch Interest
Recovery TimeGradual Weeks-Based Effect
COMPATIBILITY
Recovery StackGH Secretagogues / Peptide Research
Skin SupportCollagen-Based Approaches
Training SupportRegeneration Focus
CombinationRequires Research Evaluation
InteractionLimited Clinical Data
MECHANISM OF ACTION
BindingCopper Ion Complex Formation
FibroblastsSupports Cellular Signaling
CollagenExtracellular Matrix Regulation
Growth FactorsPotential Modulation
HealingTissue Remodeling Pathways
PHARMACOKINETICS
AbsorptionPeptide Dependent
MetabolismProteolytic Breakdown
Half-lifeLimited Human Data
DistributionTissue Interaction
EliminationPeptide Clearance Pathways
SAFETY PROFILE
Clinical DataLimited
ToxicityNot Fully Established
Injection RiskPossible Local Reaction
Immune ResponsePotential Peptide Sensitivity
MonitoringRecommended
CHEMICAL PROFILE
CompoundCopper Tripeptide-1
FormulaC14H24N6O4
ClassBiologically Active Peptide
Molecular Weight340.38 g/mol
CAS89030-95-5
OVERVIEW
Dragon Pharma GHK-CU 50 mg contains Copper Tripeptide-1, a naturally occurring peptide complex studied for its involvement in extracellular matrix regulation, collagen signaling and tissue remodeling pathways. It has attracted interest among athletes and bodybuilding communities due to potential recovery and connective tissue support applications.
BENEFITS
- Supports collagen-related pathways
- Potential connective tissue support
- Research interest in wound healing
- Supports extracellular matrix activity
- Potential skin quality improvement
- Cellular regeneration research value
POTENTIAL RISKS
- Limited long-term human data
- Possible injection site irritation
- Potential allergic response
- Unknown effects of prolonged non-medical use
- Requires sterile administration practices
CONCLUSION
Dragon Pharma GHK-CU 50 mg represents a copper-binding peptide formulation researched for cellular signaling, extracellular matrix regulation and tissue remodeling processes. Unlike anabolic hormones, GHK-CU does not function through androgen pathways and is primarily studied for regenerative biology applications.
In bodybuilding environments, interest in GHK-CU is mainly associated with recovery, connective tissue support and skin-related benefits rather than direct increases in muscle mass or strength.
Scientific understanding continues to develop, and responsible interpretation requires consideration of available clinical evidence, product quality and appropriate medical oversight.
Disclaimer
This content is provided exclusively for educational and informational purposes. It does not constitute medical advice, treatment recommendations or endorsement of non-approved peptide use. Always consider professional healthcare guidance and applicable regulations.
REFERENCES
GHK-Cu peptide and wound healing research:PubMed
FDA biological product information:FDA
Clinical peptide information resources:NCBI
European medical information database:EMA